Researcher.Life Logo

Thoracic Cancer : Impact Factor & More

eISSN: 1759-7714pISSN: 1759-7706
JournalOpen Access

Key Metrics

CiteScore
4.2
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Thoracic Cancer

Thoracic Cancer Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Semi-monthly
Article Processing ChargesUSD 2000
Publication Time41
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorChina Lung Oncology Group
FrequencySemi-monthly
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 41
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Thoracic Cancer ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Thoracic Cancer

Lobe-Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non-Small Cell Lung Cancer: A Propensity Score-Matched Analysis Based on the 8th Edition of the TNM Stage Classification.
  • 1 Jul 2026
  • Thoracic cancer
Impact of Thyroid Transcription Factor-1 Expression on Outcomes of Platinum-Based Chemoimmunotherapy in Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.
  • 1 Jul 2026
  • Thoracic cancer
Transformation or Clonal Evolution? A Rare Case Report of Pulmonary Sarcomatoid Carcinoma Developing to Small Cell Lung Cancer.
  • 1 Jul 2026
  • Thoracic cancer
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.
  • 1 Jul 2026
  • Thoracic cancer
MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib-Resistant MET-Amplified, EGFR-Mutated Non-Small Cell Lung Cancer.
  • 1 Jul 2026
  • Thoracic cancer
Clinical Manifestations and Outcomes of Lung Cancer Patients With Appendiceal Metastasis.
  • 1 Jul 2026
  • Thoracic cancer
Lobe-Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non-Small Cell Lung Cancer: A Propensity Score-Matched Analysis Based on the 8th Edition of the TNM Stage Classification.
  • 1 Jul 2026
  • Thoracic cancer
Impact of Thyroid Transcription Factor-1 Expression on Outcomes of Platinum-Based Chemoimmunotherapy in Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.
  • 1 Jul 2026
  • Thoracic cancer
Transformation or Clonal Evolution? A Rare Case Report of Pulmonary Sarcomatoid Carcinoma Developing to Small Cell Lung Cancer.
  • 1 Jul 2026
  • Thoracic cancer
An Observational Study of Afatinib 30 mg Daily in Patients With Advanced Non-Small-Cell Lung Cancer Harboring Common EGFR Mutations Treated With Afatinib.
  • 1 Jul 2026
  • Thoracic cancer
MET Dependence Oversteps EGFR Dependence via Balancing Dimerization of the Receptor Tyrosine Kinases in Osimertinib-Resistant MET-Amplified, EGFR-Mutated Non-Small Cell Lung Cancer.
  • 1 Jul 2026
  • Thoracic cancer
Clinical Manifestations and Outcomes of Lung Cancer Patients With Appendiceal Metastasis.
  • 1 Jul 2026
  • Thoracic cancer

FAQs on Thoracic Cancer